Literature DB >> 10373536

Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.

I Garcia-Higuera1, Y Kuang, D Näf, J Wasik, A D D'Andrea.   

Abstract

Fanconi anemia (FA) is an autosomal recessive cancer susceptibility syndrome with at least eight complementation groups (A to H). Three FA genes, corresponding to complementation groups A, C, and G, have been cloned, but their cellular function remains unknown. We have previously demonstrated that the FANCA and FANCC proteins interact and form a nuclear complex in normal cells, suggesting that the proteins cooperate in a nuclear function. In this report, we demonstrate that the recently cloned FANCG/XRCC9 protein is required for binding of the FANCA and FANCC proteins. Moreover, the FANCG protein is a component of a nuclear protein complex containing FANCA and FANCC. The amino-terminal region of the FANCA protein is required for FANCG binding, FANCC binding, nuclear localization, and functional activity of the complex. Our results demonstrate that the three cloned FA proteins cooperate in a large multisubunit complex. Disruption of this complex results in the specific cellular and clinical phenotype common to most FA complementation groups.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373536      PMCID: PMC84285          DOI: 10.1128/MCB.19.7.4866

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.

Authors:  M Pulsipher; G M Kupfer; D Naf; A Suliman; J S Lee; P Jakobs; M Grompe; H Joenje; C Sieff; E Guinan; R Mulligan; A D D'Andrea
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

2.  A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.

Authors:  G Kupfer; D Naf; I Garcia-Higuera; J Wasik; A Cheng; T Yamashita; A Tipping; N Morgan; C G Mathew; A D D'Andrea
Journal:  Exp Hematol       Date:  1999-04       Impact factor: 3.084

Review 3.  Fanconi anemia and novel strategies for therapy.

Authors:  J M Liu; M Buchwald; C E Walsh; N S Young
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

4.  The Fanconi anaemia group G gene FANCG is identical with XRCC9.

Authors:  J P de Winter; Q Waisfisz; M A Rooimans; C G van Berkel; L Bosnoyan-Collins; N Alon; M Carreau; O Bender; I Demuth; D Schindler; J C Pronk; F Arwert; H Hoehn; M Digweed; M Buchwald; H Joenje
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

Review 5.  Role of the human RAD51 protein in homologous recombination and double-stranded-break repair.

Authors:  P Baumann; S C West
Journal:  Trends Biochem Sci       Date:  1998-07       Impact factor: 13.807

6.  Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase.

Authors:  F A Kruyt; T Hoshino; J M Liu; P Joseph; A K Jaiswal; H Youssoufian
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

7.  The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.

Authors:  T Yamashita; G M Kupfer; D Naf; A Suliman; H Joenje; S Asano; A D D'Andrea
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

8.  Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization.

Authors:  D Näf; G M Kupfer; A Suliman; K Lambert; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity.

Authors:  F A Kruyt; H Youssoufian
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

10.  Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype.

Authors:  H Joenje; J R Lo ten Foe; A B Oostra; C G van Berkel; M A Rooimans; T Schroeder-Kurth; R D Wegner; J J Gille; M Buchwald; F Arwert
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

View more
  50 in total

1.  Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.

Authors:  H Joenje; M Levitus; Q Waisfisz; A D'Andrea; I Garcia-Higuera; T Pearson; C G van Berkel; M A Rooimans; N Morgan; C G Mathew; F Arwert
Journal:  Am J Hum Genet       Date:  2000-08-08       Impact factor: 11.025

2.  GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.

Authors:  Mark E Bernard; Hyun Kim; Hebist Berhane; Michael W Epperly; Darcy Franicola; Xichen Zhang; Frank Houghton; Donna Shields; Hong Wang; Christopher J Bakkenist; Marie-Celine Frantz; Erin M Forbeck; Julie P Goff; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2011-09-22       Impact factor: 2.841

3.  FANCE: the link between Fanconi anaemia complex assembly and activity.

Authors:  Paul Pace; Mark Johnson; Wu Meng Tan; Georgina Mosedale; Chelvin Sng; Maureen Hoatlin; Johan de Winter; Hans Joenje; Fanni Gergely; K J Patel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

4.  A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.

Authors:  Amom Ruhikanta Meetei; Salvatore Sechi; Michael Wallisch; Dafeng Yang; Mary K Young; Hans Joenje; Maureen E Hoatlin; Weidong Wang
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 5.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

6.  FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway.

Authors:  Abdullah Mahmood Ali; Arun Pradhan; Thiyam Ramsingh Singh; Changhu Du; Jie Li; Kebola Wahengbam; Elke Grassman; Arleen D Auerbach; Qishen Pang; Amom Ruhikanta Meetei
Journal:  Blood       Date:  2012-02-17       Impact factor: 22.113

7.  Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair.

Authors:  Justin Wai Chung Leung; Yucai Wang; Ka Wing Fong; Michael Shing Yan Huen; Lei Li; Junjie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-06       Impact factor: 11.205

8.  Stimulation of homology-directed repair at I-SceI-induced DNA breaks during the permissive life cycle of human cytomegalovirus.

Authors:  A S Kulkarni; E A Fortunato
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

9.  Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Weiliang Tang; Matthew Deater; Ngoc Phan; Andrea N Marcogliese; Hui Li; Muhsen Al-Dhalimy; Angela Major; Susan Olson; Raymond J Monnat; Markus Grompe
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

10.  BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks.

Authors:  Pietro Pichierri; Annapaola Franchitto; Filippo Rosselli
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.